A Double-Blind Placebo-Controlled Trial of Rozerem in Migraine Headaches
This study has been terminated.
(Failure to recruit necessary number of patients.)
Takeda Pharmaceuticals North America, Inc.
Information provided by (Responsible Party):
Patricia Shipley, MD, Charlottesville Neuroscience
First received: October 22, 2006
Last updated: February 8, 2012
Last verified: February 2012
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been terminated.|
|Study Completion Date:||October 2009|
|Primary Completion Date:||October 2009 (Final data collection date for primary outcome measure)|